<DOC>
	<DOCNO>NCT01689090</DOCNO>
	<brief_summary>The primary objective study inhibition nitric oxide and/or prostaglandin affect diameter change retinal vessel observe hypoxia . Diameter change study use Dynamic Vessel Analyzer .</brief_summary>
	<brief_title>Diameter Changes Retinal Vessels During Hypoxia</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Diclofenac</mesh_term>
	<mesh_term>Cyclooxygenase Inhibitors</mesh_term>
	<mesh_term>omega-N-Methylarginine</mesh_term>
	<mesh_term>Glucuronyl glucosamine glycan sulfate</mesh_term>
	<mesh_term>Citric Acid</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Diabetes type 1 without retinopathy Diabetic retinopathy Cardiovascular disease Lung disease Pregnancy Previous ocular disease retinal branch vein occlusion Previous treatment medication influence intraocular pressure metabolism nitric oxide prostaglandin</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>